PD‐1/PD‐L1 pathway: basic biology and role in cancer immunotherapy A Salmaninejad, SF Valilou, AG Shabgah, S Aslani, M Alimardani, ... Journal of cellular physiology 234 (10), 16824-16837, 2019 | 453 | 2019 |
Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors M Iranshahi, A Jabbari, A Orafaie, R Mehri, S Zeraatkar, T Ahmadi, ... European journal of medicinal chemistry 57, 134-142, 2012 | 59 | 2012 |
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells AS Zangouei, M Alimardani, M Moghbeli Cancer Cell International 21, 1-14, 2021 | 43 | 2021 |
Synthesis and SAR study of 4, 5-diaryl-1H-imidazole-2 (3H)-thione derivatives, as potent 15-lipoxygenase inhibitors A Assadieskandar, M Amini, M Salehi, H Sadeghian, M Alimardani, ... Bioorganic & medicinal chemistry 20 (24), 7160-7166, 2012 | 36 | 2012 |
Next-generation sequencing and its application in diagnosis of retinitis pigmentosa A Salmaninejad, J Motaee, M Farjami, M Alimardani, A Esmaeilie, ... Ophthalmic genetics 40 (5), 393-402, 2019 | 23 | 2019 |
Synthesis of new series of pyrimido[4,5-b][1,4] benzothiazines as 15-lipoxygenase inhibitors and study of their inhibitory mechanism M Nikpour, M Mousavian, M Davoodnejad, M Alimardani, H Sadeghian Medicinal Chemistry Research 22, 5036-5043, 2013 | 23 | 2013 |
Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors A Jabbari, M Davoodnejad, M Alimardani, A Assadieskandar, ... Bioorganic & medicinal chemistry 20 (18), 5518-5526, 2012 | 21 | 2012 |
The worldwide frequency of MYO15A gene mutations in patients with non-syndromic hearing loss: A meta-analysis M Farjami, R Assadi, FA Javan, M Alimardani, S Eslami, SM Derakhshan, ... Iranian Journal of Basic Medical Sciences 23 (7), 841, 2020 | 17 | 2020 |
Distribution of hepatitis delta virus genotypes in mashhad, northeast iran H Sadeghian, N Varasteh, A Esmaeelzadeh, H Nomani, M Alimardani, ... Jundishapur journal of microbiology 8 (2), 2015 | 13 | 2015 |
New Insight into the SAR of Pyrimido [4, 5-b][1, 4] Benzothiazines as 15-lipoxygenase Inhibitors N Pooryaghoobi, M Bakavoli, M Alimardani, T Bazzazan, H Sadeghian Iranian Journal of Basic Medical Sciences 16 (6), 784, 2013 | 11 | 2013 |
Targeted mutation analysis of the SLC26A4, MYO6, PJVK and CDH23 genes in Iranian patients with AR nonsyndromic hearing loss M Alimardani, SM Hosseini, MS Khaniani, MR Haghi, A Eslahi, M Farjami, ... Fetal and Pediatric Pathology 38 (2), 93-102, 2019 | 10 | 2019 |
Association of rs4784227-CASC16 (LOC643714 locus) and rs4782447-ACSF3 polymorphisms and their association with breast cancer risk among Iranian population A Tajbakhsh, Z Farjami, S Darroudi, SH Ayati, F Vakili, M Asghari, ... EXCLI journal 18, 429, 2019 | 10 | 2019 |
Advances in glioblastoma multiforme: Integrating therapy and pathology perspectives SH Shahcheraghi, M Alimardani, M Lotfi, M Lotfi, VN Uversky, ... Pathology-Research and Practice 257, 155285, 2024 | 9 | 2024 |
Genetic and molecular biology of autism spectrum disorder among Middle East population: a review Z Rahmani, MR Fayyazi Bordbar, M Dibaj, M Alimardani, M Moghbeli Human Genomics 15, 1-12, 2021 | 7 | 2021 |
Investigation of MYO15A and MYO7A mutations in Iranian patients with nonsyndromic hearing loss M Farjami, M Fathi, MM Ghasemi, M Rajati, A Eslahi, M Alimardani, ... Fetal and pediatric pathology 40 (2), 121-130, 2021 | 6 | 2021 |
Association of PICK1 and BDNF variations with increased risk of methamphetamine dependence among Iranian population: a case–control study A Tajbakhsh, M Alimardani, M Asghari, S Abedini, S Saghafi Khadem, ... BMC medical genomics 14, 1-10, 2021 | 4 | 2021 |
Distribution of hepatitis delta virus genotypes in Mashhad, Northeast Iran M Meshkat, H Sadeghian, A Esmaeelzadeh, H Nomani, M Alimardani, ... Jundishapur Journal of Microbiology 8 (2), A1, 2015 | 4 | 2015 |
The impact of probiotic cell-free metabolites in MDR Pseudomonas aeruginosa: antibacterial properties and effect on antibiotic resistance genes expression N Mehboudi, HR Rahimi, HA Bakhtiari, M Alimardani, A Jalili Letters in Applied Microbiology 76 (10), ovad111, 2023 | 3 | 2023 |
Pharmacovariome scanning using whole pharmacogene resequencing coupled with deep computational analysis and machine learning for clinical pharmacogenomics A Tafazoli, J Mikros, F Khaghani, M Alimardani, M Rafigh, M Hemmati, ... Human Genomics 17 (1), 62, 2023 | 3 | 2023 |
Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer M Alimardani, M Moghbeli, A Rastgar-Moghadam, FH Shandiz, ... Current Cancer Drug Targets 21 (9), 768-793, 2021 | 1 | 2021 |